The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.
about
Vitamin C for treating atrial fibrillationVitamin C for treating atrial fibrillationTriggers and anatomical substrates in the genesis and perpetuation of atrial fibrillationNADPH oxidases: key modulators in aging and age-related cardiovascular diseases?Meta-analysis of Vitamin D Deficiency and Risk of Atrial Fibrillation.Association between CHADS2 score and the preventive effect of statin therapy on new-onset atrial fibrillation in patients with acute myocardial infarction.Isoproterenol disperses distribution of NADPH oxidase, MMP-9, and pPKCepsilon in the heart, which are mitigated by endothelin receptor antagonist CPU0213Redox regulation, NF-kappaB, and atrial fibrillation.Statins Decrease Oxidative Stress and ICD Therapies.Comparing the therapeutic effects of carvedilol and metoprolol on prevention of atrial fibrillation after coronary artery bypass surgery, a double-blind study.Reactive gamma-ketoaldehydes formed via the isoprostane pathway disrupt mitochondrial respiration and calcium homeostasis.N-Acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trialsMultiple biomarkers and atrial fibrillation in the general populationReactive γ-ketoaldehydes promote protein misfolding and preamyloid oligomer formation in rapidly-activated atrial cells.A Circulating Biomarker Risk-Prediction Model Correlates with CHADS-2 Risk Score in Chronic Atrial Fibrillation.Antioxidant vitamins in the prevention of atrial fibrillation: what is the evidence?Incidence of cardiac arrhythmias in asymptomatic hereditary hemochromatosis subjects with C282Y homozygosityPrevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant systemXanthine oxidase and uric Acid in atrial fibrillation.Chronic atrial fibrillation associated with somatic mitochondrial DNA mutations in human atrial tissueAssociation of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study).Serum levels of nicotinamide-adenine dinucleotide phosphate oxidase 4 are associated with non-valvular atrial fibrillation.Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysisObesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation: systematic review and meta-analysis.Hydrogen Peroxide Modulates Electrophysiological Characteristics of Left Atrial Myocytes.Abrogation of Nrf2 impairs antioxidant signaling and promotes atrial hypertrophy in response to high-intensity exercise stress.Atrial fibrillation and flutter following coronary artery bypass graft surgery: A retrospective study and review.Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States.Atrial fibrillation in end-stage renal disease.Clinical use of and future perspectives on antiarrhythmic drugs.Xanthine oxidoreductase in respiratory and cardiovascular disorders.Hyperuricemia and Risk of Atrial FibrillationUnderstanding and Managing Atrial Fibrillation in Patients with Kidney Disease.Pleiotropic effects of statins in atrial fibrillation patients: the evidence.Antioxidant therapies for the management of atrial fibrillation.Diabetes, Obesity and Atrial Fibrillation: Epidemiology, Mechanisms and InterventionsIs there a role for statins in atrial fibrillation?Low-dose green tea intake reduces incidence of atrial fibrillation in a Chinese population.Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation.
P2860
Q24186942-785E0505-9B59-4702-9FAC-3F80AD58F0B2Q26471829-B32941DE-8D7E-49AF-9527-396B144DD355Q26858987-C72923FC-255A-442E-B276-0C83E332712BQ28072348-951B18CF-CDCD-438B-B96D-72D2DBC65064Q30248327-8F96A0D2-8F53-4974-AB5C-EB29335B9267Q31134080-46663533-66BA-47FF-A88F-BD8A8E93D9E7Q33552820-89194E02-B50B-4FA4-8B52-5D7750F83A4BQ33644314-3BB24E12-4733-4A8E-9B73-85A2AA83D3C2Q33760881-FB49E115-488E-484D-BCF4-5FB61A50D546Q33942418-D0241D29-15FB-4CE6-8CF7-6338146498BFQ33992448-391ED135-6FA7-4B46-9C93-4CE5BFE01499Q34171904-FDBBB3E2-466D-4C83-925A-D5EDC3D52753Q34525092-3CE2EB70-B422-49F1-9B7B-46F7FCBEAF8BQ34995740-ED108058-99AC-4306-B51A-35DC824B022EQ35105438-00116899-4322-4341-B6CE-185DEEC3C80DQ35184349-540628CE-DC84-4B48-B4D8-F8E40BA87863Q35803531-93F61A81-32D0-4457-8C1C-6D3DEB251697Q35885268-F457BC91-7F19-4310-90AA-D4417D1D4342Q35985640-EB1DFDE5-4E4A-48D8-8401-672BA049B096Q36014214-DB853F30-C883-4EEA-9549-6AD1FEA8887EQ36113099-85CA4261-0318-46EF-9649-A1EB8F93D0B2Q36321530-4BE4362F-5D5B-4842-850D-84D92766C641Q36337187-91D6E0C5-77EA-4395-8187-03E84481E231Q36382360-A423D5D8-D8F5-4F3A-B303-025D8113A2E2Q36483822-38F42999-D86F-4604-AAC7-DF749EA2E9D1Q36721269-CAF81F1F-35A6-4C18-98DD-EA938A0F6529Q36769369-EE22D566-2AA6-4892-91E4-35153C302201Q36806162-02B45A3C-87DA-4CF4-AA6B-19E757A2103FQ36808315-57176F13-FA94-4A92-9F17-78442084EAB2Q36988390-2A5FA14C-619B-4A30-9712-0730801A36A3Q37002176-91DE4270-3063-426C-B02E-DF78DD69CC18Q37111434-2FBFCF5D-93E9-49DC-A271-DCC5CB8DDEB8Q37115135-2C98D081-D07F-4C50-BEFA-E290DC51732AQ37115706-899E34C5-7D94-4599-8CB4-B9FF1E82CCCAQ37248230-82428F76-01C0-49D4-AB60-C58720FEA5EAQ37339307-B74C8AAE-6D65-422E-A2F8-3F8951F2F479Q37496314-53700EC1-4FB0-431D-B56B-AECD2F4F05A4Q37573895-2E9E384E-B3CB-477F-98FF-2157917210ADQ37709192-FE0E6B02-2079-4759-ABD6-923F58B58393Q37975121-045BE68C-29E5-4D00-929C-FFDC9038BF7A
P2860
The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.
@ast
The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.
@en
type
label
The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.
@ast
The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.
@en
prefLabel
The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.
@ast
The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.
@en
P2093
P1476
The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.
@en
P2093
Dimitrios Galaris
John A Goudevenos
Panagiotis Korantzopoulos
Theofilos M Kolettis
P304
P356
10.1016/J.IJCARD.2006.04.026
P577
2006-06-09T00:00:00Z